Better use of cytokine signalizing could 'revolutionize' rheumatology treatment

Correctly identifying cytokine pathways that are dysregulated in any given rheumatology patient could lead to better use of current biologic therapies, said a presenter at the 2022 Association of Women in Rheumatology annual conference.

Related Keywords

South Carolina , United States , Hilton Head Island , Iainb Mcinnes , Iain Mcinnes , Shenaz Bagha , Byrob Volansky , Glaxosmithkline , Amgen , University Of Glasgow , Compugen , Novartis , Eli Lilly Co , Pfizer , Association Of Women , Wellcome , Bristol Myers Squibb , Causeway Therapeutics , Eli Lilly ,